Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anai, M.
Right arrow Articles by Asano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anai, M.
Right arrow Articles by Asano, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 45, 29686-29692, November 6, 1998


Different Subcellular Distribution and Regulation of Expression of Insulin Receptor Substrate (IRS)-3 from Those of IRS-1 and IRS-2*

Motonobu AnaiDagger , Hiraku Ono, Makoto FunakiDagger , Yasushi Fukushima, Kouichi InukaiDagger , Takehide Ogihara, Hideyuki Sakoda, Yukiko Onishi, Yoshio Yazaki, Masatoshi KikuchiDagger , Yoshitomo Oka§, and Tomoichiro Asano

From The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, the Dagger  Institute for Adult Diseases, Asahi Life Foundation, 1-9-14 Nishishinjuku, Shinjuku-ku, Tokyo 116, and the § Third Department of Internal Medicine, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Adipocytes contain three major substrate proteins of the insulin receptor, termed IRS-1, IRS-2, and IRS-3. We demonstrated that IRS-1 and IRS-2 are located mainly in the low density microsome (LDM) fraction and are tyrosine phosphorylated in response to insulin stimulation, leading to phosphatidylinositol (PI) 3-kinase activation. In contrast, IRS-3 is located mainly in the plasma membrane (PM) fraction and contributes to PI 3-kinase activation in the PM fraction. The different cellular localizations of IRS proteins may account for the mechanism of insulin resistance induced by a high fat diet, considering that PI 3-kinase activation in the LDM fraction is reportedly essential for the translocation of GLUT4 in adipocytes. High fat feeding in rats increased both protein and mRNA levels of IRS-3 but decreased those of IRS-1 and IRS-2 in epididymal adipocytes. As a result, selective impairment of insulin-induced PI 3-kinase activation was observed in the LDM fraction, whereas PI 3-kinase activation was conserved in the PM fraction. This is the first report showing that different IRS proteins function in different subcellular compartments, which may contribute to determining the insulin sensitivity in adipocytes.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Insulin induces numerous cell activities in adipose tissue, which include cell proliferation and differentiation, stimulation of glucose uptake, inhibition of lipolysis, translocation of various membrane proteins such as transferrin receptor and insulin-like growth factor II receptor, and synthesis and/or secretion of leptin (1-3). Although it remains unclear which step in the insulin signaling pathway is related to each of these individual activities, it seems certain that insulin-stimulated phosphatidylinositol 3-kinase (PI 3-kinase)1 activation plays a critical role in the translocation of GLUT4 from intracellular vesicles to the cell surface (4-6). In addition, Yang et al. (7) suggested that PI 3-kinase activation in the intracellular compartment, but not on the plasma membrane, is necessary for the efficient translocation of GLUT4 (7).

In adipocytes it has been reported that not only IRS-1 and IRS-2, but also a protein of approximately 60 kDa referred to as pp60, are major substrates that are tyrosine phosphorylated by the insulin receptor (8-10). Recently, pp60 was cloned and termed IRS-3 in rat and mouse adipocytes, and its structure was shown to have several similarities to IRS-1 and IRS-2 (11, 12). Sequence alignment of IRS-3 with the other members of the IRS family revealed that these IRS proteins contain pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains that are highly conserved (11, 12). In addition, there is conservation of many tyrosine phosphorylation motifs responsible for interactions with downstream signaling molecules containing SH2 domains, including PI 3-kinase. However, IRS-3 is far smaller than IRS-1/2 and has some regions that have no homology to IRS-1/2. Therefore, IRS-3 may have some unique role in insulin signaling and glucose metabolism. IRS-1 and IRS-2 have been shown to participate in the insulin signaling pathway whereby insulin stimulates translocation of GLUT4 in adipose cells (13, 14).

The aim of this study was to clarify the unique role of IRS-3 compared with IRS-1 and IRS-2. Our data suggest that different IRS proteins may be important in the activation of SH2-containing proteins including PI 3-kinase in different subcellular compartments, which may induce different cellular activities. In addition, we investigated how the expression levels of IRS-3 as well as IRS-1 and IRS-2 are regulated in high fat-fed rat adipocytes, in which insulin resistance is present. The different regulation of IRS-3 from that of IRS-1 and IRS-2 would induce a different degree of PI 3-kinase activation in the different subcellular locations, which may be involved in the pathogenesis of insulin resistance. This is the first paper showing the different role of IRS-3 and also suggesting the possibility that the difference in regulation of expression of IRS proteins may affect insulin sensitivity in fat cells.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- Bovine serum albumin, fraction V, was purchased from Intergen (Purchase, NY). Collagenase and PI were purchased from Sigma (St. Louis, MO). Insulin was purchased from Novo Nordisk (Denmark). [gamma -32P]ATP was purchased from ICN (Costa Mesa, CA). Aluminum-backed silica gel thin layer chromatographic plates were purchased from Merck (Darmstadt, Germany). Protein A-Sepharose 6MB was purchased from Amersham Pharmacia Biotech (U. K). All other chemicals were purchased from Wako (Osaka, Japan).

Animals-- Male Sprague-Dawley rats, 5 weeks old and 110-140 g, were purchased from Tokyo Experimental Animals (Tokyo, Japan) and housed under controlled light (12/12 h) and temperature conditions with free access to food and water.

After a 2-3-day acclimatization period, the rats were divided into a normal chow group and a high fat diet group and fed ad libitum for 2 weeks. The high fat diet consisted of 58% lard (w/w), 30% fish powder, 10% skimmed milk, and a 2% vitamin and mineral mixture (equivalent to 7.5% carbohydrate, 24.5% protein, and 60% fat). The normal chow proportions were 54% carbohydrate, 20% protein, and 4.5% fat.

Antibodies-- Specific antibodies against IRS-1 and IRS-2 were prepared as described previously (15). The antibody against IRS-3 was prepared by immunizing rabbits with a synthetic peptide derived from its specific amino acid sequence of the carboxyl terminus (PPLEVPGAAPGNSPHSYASIKF). Anti-p85alpha antibody and anti-phosphotyrosine antibody (4G10) were purchased from Upstate Biochemistry (Lake Placid, NY).

Isolation of Adipocytes and Insulin Stimulation-- All of the rats were killed by decapitation after 12-14 h of fasting. Isolated adipocytes were prepared from epididymal fat pads by shaking at 37 °C for 20 min in Krebs-Ringer bicarbonate buffer containing collagenase (3 mg/ml) and bovine serum albumin (10 mg/ml), according to the methods of Robdell (16).

Isolated adipocytes were preincubated in 1% bovine serum albumin and Krebs-Ringer bicarbonate buffer for 15 min and then stimulated with 10-7 M insulin for 5 min. After insulin stimulation, adipocytes were washed three times with HES buffer (20 mM Hepes, pH 7.5, 1 mM EDTA, 255 mM sucrose, 10 mM NaF, 1 mM sodium pyrophosphate) and used for PI 3-kinase assay or Western blotting immediately or after cell fractionation.

Cell Fractionation-- Isolated adipocytes incubated with or without insulin were homogenized and fractionated as described previously by Simpson et al. (17) with several modifications. 1 volume of HES buffer with 1 mM vanadate, 1 µg/ml aprotinin, 1 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride was added to isolated adipocytes, and the mixture was homogenized by 10 strokes in a Potter-Elvehjem Teflon pestle homogenizer. The homogenates were centrifuged at 16,000 × g for 15 min at 4 °C, the solidified fat cake was removed carefully, and the supernatant was saved for preparation of the microsomal membrane fraction. The initial pellet was resuspended and recentrifuged once before being resuspended in 5 ml of buffer, applied to a 1.12 M sucrose cushion containing 20 mM Tris-HCl and 1 mM EDTA, and centrifuged at 101,000 × gmax for 70 min. The mitochondria, nuclei, and cell debris were collected as a pellet; however, in this experiment, we did not analyze this fraction further. The plasma membranes (PM), collected at the interface, were resuspended in 50 ml of buffer and centrifuged at 48,000 × gmax for 45 min. The pellet was resuspended at approximately 2 mg of protein/ml.

The initial supernatant was centrifuged at 48,000 × gmax for 20 min, yielding a pellet of high density microsomal membranes (HDM). The supernatant was then recentrifuged at 212,000 × gmax for 70 min, yielding a second pellet of low density microsomal membranes (LDM), and the remaining supernatant was condensed by Centricon-30 and used as cytosol. All pellets were resuspended in 1-10 ml of buffer and repelleted before final resuspension at 1 mg of protein/ml.

PI 3-Kinase Assay-- Isolated adipocytes were prepared, and some were stimulated with insulin as described above. Subcellular fractions were separated as described above, and precipitated fractions were resuspended in ice-cold buffer A (50 mM Hepes, pH 7.5, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 2 mM Na3VO4, 10 mM sodium pyrophosphate, 10 mM NaF, 2 mM EDTA, 1% Nonidet P-40, 10% glycerol, 2 µg/ml aprotinin, 5 µg/ml leupeptin, and 34 µg/ml phenylmethylsulfonyl fluoride). Protein concentrations were determined by BCA protein assay using bovine serum albumin as the standard. IRS-1, IRS-2, IRS-3, and tyrosine-phosphorylated proteins were immunoprecipitated from aliquots of the supernatant containing 1 mg of protein with anti-IRS-1, anti-IRS-2, anti-IRS-3, or 4G10 antibodies, respectively, followed by protein A-Sepharose 6MB. The assays of PI 3-kinase activities in the immunoprecipitates were performed as described previously (15).

Western Blotting-- Isolated adipocytes were prepared, and some were stimulated with insulin as described above. For total cellular homogenates, isolated adipocytes were homogenized in ice-cold buffer B (50 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM EGTA, 100 mM NaF, 10 mM sodium pyrophosphate, 10% glycerol, 1.5 mM MgCl2, 1% Triton X-100, 1 mM Na3VO4, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride) and kept on ice for 30 min. The homogenates were subjected to centrifugation at 15,000 × g for 30 min at 4 °C, the solidified fat cake was removed carefully, and the supernatants were used as samples. Subcellular fractions were separated as described above, and precipitated fractions were resuspended in ice-cold buffer B. The protein concentration was determined by BCA protein assay using bovine serum albumin as the standard, and the concentrations were adjusted to 1 mg/ml. IRS-1, IRS-2, IRS-3, and tyrosine-phosphorylated proteins were immunoprecipitated from each supernatant containing 1 mg of protein with 2 µg/ml anti-IRS-1, anti-IRS-2, anti-IRS-3, or 4G10 antibodies, respectively, followed by protein A-Sepharose 6MB, so that the efficiency of immunoprecipitation was the same among the samples of fractions. In some experiments, anti-IRS-3 antibody was chemically cross-linked with protein A-Sepharose 4FF to decrease the amount of immunoglobulin heavy chain in the immunoprecipitate and to detect the amount of IRS-3 protein the in immunoprecipitates. Immunoprecipitates were washed three times with buffer B and boiled in Laemmli sample buffer containing 100 mM dithiothreitol. Aliquots of samples were subjected to SDS-PAGE (7.5% or 10%). Electrotransfer of proteins from the gel to PVDF membrane was performed for 3 h at 80 V (constant); immunoblotting with each of the aforementioned antibodies was performed with Enhanced Chemiluminescence (ECL), and band intensities were quantified with a PhosphorImager GS-525 using Imaging Screen CH.

RNase Protection Assay-- In vitro transcription for riboprobe and RNase protection assay was performed as described previously (15). A rat IRS-3 cDNA corresponding to nucleotides 982-1526 was obtained by polymerase chain reaction based on the reported sequence. The 544 base pairs of rat IRS-3 cDNA were subcloned in pBluescript2 SK+ and used for in vitro transcription. Pooled samples of 20 µg of total RNA from adipose tissue were used and hybridized with the riboprobe of IRS-1, IRS-2, or IRS-3. After treatment with RNase, the protected fragments were resolved on 5% polyacrylamide-urea gel, subjected to autoradiography, and the band intensities were determined by PhosphorImager GS-525 using Imaging Screen BI.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Efficiency of Immunodepletion of Anti-IRS-3 Antibody and Immunospecificity of Anti-IRS-1/2 Antibody-- To determine the efficiency of immunoprecipitation with anti-IRS-3 antibody, the amount of IRS-3 in the supernatant after immunoprecipitation was determined. As shown in Fig. 1, IRS-3 in the second immunoprecipitation was only 6% of that in the first. These results indicate that the anti-IRS-3 antibody used in this study immunodepleted IRS-3 from the cell lysate effectively.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Efficiency of immunodepletion of anti-IRS-3 antibody and immunospecificity of anti-IRS-1/2 antibody. Panel A, a cell lysate of isolated adipocytes was prepared as described under "Experimental Procedures." 1 mg of cell lysate was incubated for 2 h at 4 °C with anti-IRS-3 antibody that chemically cross-linked with protein A-Sepharose 4FF. After centrifugation, the supernatant was removed and used subsequently for another two immunoprecipitations. Immunoprecipitates were boiled as described under "Experimental Procedures" and subjected to SDS-PAGE. Immunoblotting was performed with anti-IRS-3 antibody to detect IRS-3 (upper panel). The bar graph represents the amount of IRS-3 in the first (1), second (2), and third (3) immunoprecipitates. Panel B, a cell lysate of isolated adipocytes was prepared, and 1 mg of cell lysate was immunoprecipitated with anti-IRS-1 and anti-IRS-2 antibody. Immunoprecipitates were subjected to SDS-PAGE, transferred to PVDF membrane, and immunoblotted with anti-IRS-1 antibody.

The specificity of anti-IRS-1 and anti-IRS-2 antibody was demonstrated. As shown in Fig. 1B, IRS-1 was detected in anti-IRS-1 immunoprecipitates, whereas IRS-1 was not detected in anti-IRS-2 immunoprecipitates by anti-IRS-1 immunoblotting. IRS-2 was also detected in anti-IRS-2 immunoprecipitates, although it was not detected in anti-IRS-1 immunoprecipitates (data not shown). These results indicate that the anti-IRS-1 and anti-IRS-2 antibodies used in this study recognized specific proteins.

Subcellular Localization of IRS-3 Different from That of IRS-1 and IRS-2 in Adipocytes-- The subcellular localization of IRS-1, IRS-2, and IRS-3 protein in isolated adipocytes was investigated in the presence or absence of insulin stimulation. After homogenization, the cell lysate of fat cells was fractionated into fractions of PM, HDM, LDM, and cytosol. Indicated amounts of protein from each fraction were immunoprecipitated with specific antibodies, electrophoresed, and immunoblotting was performed using the specific antibody against IRS-1, IRS-2, or IRS-3 (Figs. 2A, 3A, and 4, top panel, respectively). IRS-1 and IRS-2 were revealed to be most abundant in the LDM sample. In contrast, IRS-3 was more abundant in the PM sample and was also present in the LDM sample.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Subcellular localization of IRS-1 in isolated adipocytes. The epididymal fat pad was excised, and adipocytes were isolated as described under "Experimental Procedures." Isolated adipocytes were incubated with or without insulin for 5 min at 37 °C, and PM, LDM, HDM, and cytosol (Cyt) were prepared as described. Aliquots of each fraction (1 mg) were incubated with anti-IRS-1 antibody and subsequently precipitated by adding protein A-Sepharose 4FF. Immunoprecipitates were subjected to SDS-PAGE and transferred to PVDF membrane. Immunoblotting was performed with anti-IRS-1, anti-phosphotyrosine antibody (4G10), and anti-p85 antibody to measure IRS-1 protein (panel A), tyrosine phosphorylation of IRS-1 (panel B), and p85alpha associated with IRS-1 (panel C), respectively. In addition, PI 3-kinase activity in the anti-IRS-1 immunoprecipitate from each fraction was assayed as described under "Experimental Procedures" (panel D).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   Subcellular localization of IRS-2 in isolated adipocytes. The epididymal fat pad was excised, and adipocytes were isolated as described under "Experimental Procedures." Isolated adipocytes were incubated with or without insulin for 5 min at 37 °C, and PM, LDM, HDM, and cytosol (Cyt) were prepared as described. Aliquots of each fraction (1 mg) were incubated with anti-IRS-2 antibody and subsequently precipitated by adding protein A-Sepharose 4FF. Immunoprecipitates were subjected to SDS-PAGE and transferred to PVDF membrane. Immunoblotting was performed with anti-IRS-2, anti-phosphotyrosine antibody (4G10), and anti-p85 antibody to measure IRS-2 protein (panel A), tyrosine phosphorylation of IRS-2 (panel B), and p85alpha associated with IRS-2 (panel C), respectively. In addition, PI 3-kinase activity in the anti-IRS-2 immunoprecipitate from each fraction was assayed as described under "Experimental Procedures" (panel D).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 4.   Subcellular localization of IRS-3 in isolated adipocytes. The epididymal fat pad was excised, and adipocytes were isolated as described under "Experimental Procedures." Isolated adipocytes were incubated with or without insulin for 5 min at 37 °C, and PM, LDM, HDM, and cytosol (Cyt) were prepared as described. Aliquots of each fraction (1 mg) were incubated with anti-IRS-3 antibody and subsequently precipitated by adding protein A-Sepharose 4FF. Immunoprecipitates were subjected to SDS-PAGE and transferred to PVDF membrane. Immunoblotting was performed with anti-IRS-3, anti-phosphotyrosine antibody (4G10), and anti-p85 antibody to measure IRS-3 protein (top panel), tyrosine phosphorylation of IRS-3 (second panel from top), and p85alpha associated with IRS-3 (third panel from top). In addition, PI 3-kinase activity in the anti-IRS-3 immunoprecipitate from each fraction was assayed as described under "Experimental Procedures" (bottom panel).

Treatment with insulin at 37 °C for 5 min did not significantly affect the subcellular distributions of IRS-1, IRS-2, and IRS-3 but did induce their marked tyrosine phosphorylation (Figs. 2B, 3B, and 4, second panel from top, respectively). The tyrosine phosphorylation of IRS-1 and IRS-2 was detected mainly in the LDM sample, whereas that of IRS-3 was detected more strongly in the PM sample than in the LDM sample. These results of phosphorylation level are in good accordance with the results of the subcellular distribution of each IRS protein.

Similar results were obtained regarding the amount of p85alpha , a regulatory subunit of PI 3-kinase, associated with each of the IRS proteins, when stimulated with insulin. In the insulin-stimulated condition, p85alpha associated with IRS-1 and IRS-2 was detected predominantly in the LDM sample (Figs. 2C and 3C, respectively), whereas that associated with IRS-3 was detected mainly in the PM, but a smaller amount was also detectable in the LDM sample (Fig. 4, second panel from bottom).

PI 3-Kinase Activity Associated with IRS-1, IRS-2, and IRS-3 in Each Fraction of Isolated Adipocytes-- The subcellular localization of PI 3-kinase activity in anti-IRS-1, anti-IRS-2, and anti-IRS-3 antibody immunoprecipitates from isolated adipocytes was investigated (Figs. 2D, 3D, and 4, bottom panel, respectively). Enhancement of the kinase activity by insulin stimulation was observed irrespective of the fraction. In anti-IRS-1 and anti-IRS-2 antibody immunoprecipitates, the majority of PI 3-kinase activity was detected in LDM, and the activity in the PM samples was less than 10% of that in the LDM samples. In contrast, PI 3-kinase activity associated with IRS-3 was detected mainly in the PM, and a much lower activity was detected in the LDM samples.

Taking the different total amounts of protein obtained from each of the subcellular fractions into consideration, the distribution of each IRS protein, the tyrosine phosphorylation level, and PI 3-kinase protein and activity associated with each IRS protein were calculated in whole PM, LDM, HDM, and cytosol fractions and are summarized in Table I. Briefly, 74% and 69% of the PI 3-kinase activity associated with IRS-1 and IRS-2, respectively, were detected in the LDM fraction in the insulin-stimulated condition, whereas 77% of that associated with IRS-3 was detected in the PM fraction.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Protein characteristics in IRS
Based on the data presented in Figs. 2-4 and the total amounts of protein prepared as the samples of PM, LDM, HDM, and cytosol, the distribution of the protein, tyrosine phosphorylation level, associated PI 3-kinase protein, and activity in each fraction were calculated for each of IRS-1, IRS-2, and IRS-3. The data are presented so that total amounts or activities in the whole cell are 100% for each IRS protein in the insulin-stimulated condition.

High Fat Diet Feeding Up-regulates IRS-3 but Down-regulates IRS-1 and IRS-2-- It is well known that a high fat diet induces the enlargement of adipocytes and also insulin resistance in glucose uptake. A diet high in fat or a normal diet was given to rats for 2 weeks, and epididymal fat cells were used to investigate the regulation of expression levels of IRS-1, IRS-2, and IRS-3. An RNase protection assay and immunoblotting were performed to measure the amounts of mRNA and protein, respectively. The high fat diet decreased mRNA levels of IRS-1 and IRS-2 by 24 and 27% (Fig. 5, A and B), respectively, compared with the controls, whereas the mRNA level of IRS-3 was up-regulated significantly by 49% (Fig. 5C). Similar regulation was observed regarding the protein levels. IRS-1 and IRS-2 proteins in high fat-fed rat adipocytes were revealed to be decreased by 27 and 52%, respectively, compared with the controls (Fig. 5, D and E), whereas IRS-3 protein level was increased by 282% (Fig. 5F).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of high fat diet on expression of IRS-1, IRS-2, and IRS-3 in isolated adipocytes. RNA in the epididymal fat pad was isolated as described under "Experimental Procedures." Then 20 µg of total RNA was used for RNase protection assay with radiolabeled antisense riboprobes for IRS-1, IRS-2, and IRS-3 mRNA. Protected fragments were resolved on 5% polyacrylamide urea gel, subjected to autoradiography, and RNase-protected band intensities were analyzed with a PhosphorImager. The images show RNase-protected bands from three control and three high fat-fed rats. The bar graph represents quantitation of the results of three independent experiments. Results are indicated as percent of control (panels A-C). Total cell homogenate was prepared as described under "Experimental Procedures." IRS-1, IRS-2, and IRS-3 were immunoprecipitated with their specific antibodies. The amounts of IRS proteins were determined by immunoblotting with the specific antibodies against each of the IRS proteins. * indicates a significant difference from the control at p < 0.05; ** indicates a significant difference from the control at p < 0.01

These results indicate that the expression level of IRS-3 is regulated differently from that of IRS-1 and IRS-2 and that these different regulations are likely to act at the transcriptional level.

Effects of High Fat Diet on IRS Protein Content in PM and LDM Fractions in Adipocytes-- LDM and PM fractions were prepared from adipocytes of high fat-fed rats and control rats. The amount of IRS-1 in the PM of normal diet rats was 11% of that in LDM (Fig. 6A). The amount of IRS-1 in the adipocytes of high fat-fed rats in both PM and LDM was decreased by 31 and 74%, respectively, compared with the controls. Thus, the effect of a high fat diet on IRS-1 protein amount was more pronounced in LDM.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of high fat diet on protein levels of IRS-1, IRS-2, and IRS-3 in plasma membrane and low density microsome of isolated adipocytes. Aliquots of fractionated homogenate were immunoprecipitated with anti-IRS-1, anti-IRS-2, and anti-IRS-3 antibodies and subsequently with protein A-Sepharose 4FF. Immunoprecipitates were subjected to SDS-PAGE, transferred to PVDF membrane, and immunoblotted with specific antibodies using an ECL plus kit. The quantitation was performed with a Bio-Rad PhosphorImager with Screen-CH. The bar graph represents quantitation of the representative results of three independent experiments. Results are presented as % of each protein level in LDM of normal diet rats. Protein levels of IRS-1, IRS-2, and IRS-3 are represented in panels A, B, and C, respectively.

IRS-2 expression was also dominant in the LDM in adipocytes of normal diet rats. The high fat diet reduced the IRS-2 protein level in both PM and LDM compared with normal diet by 24 and 59%, respectively. Taken together, in high fat-fed rat adipocytes, the decreases in IRS-1 and IRS-2 content were more marked in the LDM fraction than those in the PM fraction. In contrast, the amount of IRS-3 protein was demonstrated to be increased similarly in both PM (by 62%) and LDM fractions (by 26%).

Effect of High Fat Diet on PI 3-Kinase Activity Associated with Anti-IRS-1, Anti-IRS-2, Anti-IRS-3, and Anti-phosphotyrosine Immunoprecipitates in PM and LDM-- The PI 3-kinase activity associated with anti-IRS-1, anti-IRS-2, and anti-IRS-3 immunoprecipitates was determined. The high fat diet decreased the PI 3-kinase activity associated with IRS-1 and IRS-2 after insulin stimulation in the LDM by 46 and 43%, respectively. In contrast, the PI 3-kinase activity associated with IRS-3 after insulin stimulation was significantly increased in both LDM and PM fractions by high fat diet.

Panel C of Fig. 7 demonstrates the PI 3-kinase activity associated with anti-IRS-3 immunoprecipitates. The high fat diet increased PI 3-kinase activity associated with anti-IRS-3 immunoprecipitates in the basal state (PM, 1.7-fold; LDM, 1.9-fold). Insulin-induced PI 3-kinase activation associated with anti-IRS-3 immunoprecipitates was also increased by a high fat diet in both PM and LDM (PM, 1.5-fold; LDM, 2.4-fold).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of high fat diet on PI 3-kinase activity associated with anti-IRS-1, anti-IRS-2, anti-IRS-3, and anti-phosphotyrosine immunoprecipitates in plasma membrane and low density microsome of isolated adipocytes. Aliquots of fractionated homogenate were immunoprecipitated with anti-IRS-1, anti-IRS-2, and anti-IRS-3 antibodies and subsequently with protein A-Sepharose 6MB. PI 3-kinase assay for each immunoprecipitate was performed as described under "Experimental Procedures." The quantitation was performed with a Bio-Rad PhosphorImager with Screen-BI. The bar graph represents quantitation of the representative results of three independent experiments. Results are presented as the percent of each insulin-stimulated PI 3-kinase activity in LDM of normal diet rats. PI 3-kinase activity associated with anti-IRS-1, anti-IRS-2, anti-IRS-3, and anti-phosphotyrosine antibody is represented in panels A, B, C, and D, respectively.

PI 3-kinase activity associated with anti-phosphotyrosine immunoprecipitates may represent the increment of those (associated with) anti-IRS-1, anti-IRS-2, and anti-IRS-3 immunoprecipitates. Fig. 7D demonstrates that insulin-induced PI 3-kinase activation associated with anti-phosphotyrosine antibody was decreased in both PM and LDM in high fat-fed rats by 10 and 40%, respectively.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Insulin exerts numerous cellular activities in various cells. Insulin signaling is initiated by the binding of insulin to its specific receptor on the cell surface. By the activated insulin receptor tyrosine kinase, several substrates reportedly are phosphorylated on their tyrosine residues. In rat adipocytes, not only IRS-1 and IRS-2, but also pp60, were found to be major substrates of the insulin receptor (1-3). Recently, pp60 was cloned from rat and mouse adipocytes and termed IRS-3 (11, 12). IRS-3 was shown to contain an amino-terminal PH domain, followed by a PTB domain, and these domains are highly homologous (about 50% identical amino acids) to those of IRS-1 and IRS-2 (11, 12). In addition, there is conservation of many tyrosine phosphorylation motifs responsible for interactions with downstream signaling molecules containing SH2 domains including PI 3-kinase, SHP2, and Grb-2 (12). Thus, to date no functional difference of IRS-3 from IRS-1 and IRS-2 has been reported.

IRS-3 mRNA is expressed abundantly in adipocytes and hepatocytes but is also highly expressed in the first part of embryonic life, when IRS-1 mRNA is barely detected (11). These results suggest that IRS-3 may be responsible not only for the regulation of metabolic functions in adipocytes and hepatocytes but also for differentiation and/or proliferation.

In this study we used specific antibodies for IRS-1, IRS-2, and IRS-3 and determined the subcellular localization of these proteins and PI 3-kinase activity mediated by each of these insulin receptor substrates. Insulin-stimulated PI 3-kinase activity associated with IRS-1 and IRS-2 was located mainly in the LDM (74 and 69% of total activity in cells, respectively), whereas it was barely detected in plasma membrane (19 and 15% of total activity in cells, respectively) (Table I). In fact, IRS-1 and IRS-2 proteins were barely detected in PM. Because increased amounts of IRS-1 and IRS-2 in the LDM were not detected in our experimental condition, PI 3-kinase activation associated with IRS-1 and IRS-2 in LDM resulted from an increase in the PI 3-kinase associated with the YMXM motif in IRS-1 and IRS-2 phosphorylated on tyrosine residues by insulin.

Heller-Harrison et al. (18) reported that insulin action on 3T3-L1 adipocytes progressively decreased the amount of IRS-1 protein associated with the LDM fraction. Although we could not observe a similar decrease in IRS-1 in the LDM of isolated rat adipocytes, we speculate that this contradiction may be caused by differences of the cell types and/or experimental conditions such as serum starvation.

In contrast to the case of IRS-1 and IRS-2, IRS-3 protein was detected in both PM and LDM, irrespective of stimulation with insulin. As reflected by the subcellular distribution of IRS-3, 77% of the PI 3-kinase activity associated with IRS-3 in the whole cell was detected in the PM fraction, and only 12% was in the LDM fraction (Table I). Thus, only IRS-3 efficiently contributes to the insulin-induced PI 3-kinase activation on the plasma membrane in adipocytes.

Although it remains unclear how the subcellular distributions of these signaling molecules are determined, it seems that the PH domain plays an important role in anchoring the protein to the membrane via its association with phospholipid (19, 20). On the other hand, the PTB domain of IRS proteins is reportedly essential for association with the insulin receptor (21). Therefore, the NH2-terminal portion containing the PH domain and PTB domain could have some role in determining the location of IRS proteins. However, because these portions are highly conserved between IRS-3 and IRS-1/2, it is quite unlikely that these portions contribute to their different subcellular distributions. Because there is no extended homology in the portion outside the PH and PTB domains between IRS-3 and either IRS-1 or IRS-2, it seems reasonable to consider that there is a region other than PH and PTB domains responsible for the different subcellular distributions. Further study is necessary to clarify this issue.

Insulin induces numerous cell activities in adipose tissue, which include cell proliferation and differentiation, stimulation of glucose and amino acid uptake, inhibition of lipolysis and translocation of various membrane proteins such as transferrin receptor and insulin-like growth factor II receptor, and synthesis and/or secretion of leptin (1-3). Among them, insulin-stimulated PI 3-kinase activation plays a critical role in the translocation of GLUT4 from intracellular vesicles to the cell surface (4-6). In addition, Yang et al. (7) suggested that PI 3-kinase activation in the intracellular compartment, but not on the PM, is necessary for the translocation of GLUT4, because treatment with epidermal growth factor or platelet-derived growth factor, which stimulate PI 3-kinase activity in the whole cell as strongly as insulin, failed to induce translocation of the glucose transporter to the cell surface as fully as that with insulin (7). Assuming that this is the case, PI 3-kinase activation on the plasma membrane by IRS-3 may not contribute to insulin-induced GLUT4 translocation, but one in LDM by IRS-1 and IRS-2 may be much more important to contribute to insulin-induced GLUT4 translocation.

A high fat diet is one of the major causes inducing insulin resistance with respect to the insulin-induced translocation of GLUT4 to the cell surface (22-26). We demonstrated that high fat diet up-regulates IRS-3 but down-regulates IRS-1 and IRS-2. As reflected by these altered expression levels, PI 3-kinase activation associated with IRS-1 and IRS-2 was decreased markedly, whereas that associated with IRS-3 was increased. Because IRS-3 and IRS-1/2 are located mainly in the PM and LDM, respectively, as a consequence of their altered expression levels, insulin-induced PI 3-kinase activation is impaired markedly in the LDM, whereas that on the PM is maintained. We speculate that this abnormality in the portion in the cell where PI 3-kinase activation occurs may be one of the mechanisms causing insulin resistance in high fat diet-induced insulin resistance, in terms of glucose uptake.

Although the role of PI 3-kinase activation on the PM induced by IRS-3 in adipocytes remains unclear, several possibilities can be raised. Treatment of adipocytes with platelet-derived growth factor, epidermal growth factor, or fibroblast growth factor reportedly induces a decrease in the number of developing fat cells and the activity of glycerol-3-phosphate dehydrogenase, a marker of adipocyte differentiation (27). In addition, this inhibitory action regarding the adipocyte differentiation was associated with markedly potent stimulation of cell proliferation. The inhibitory effect of platelet-derived growth factor and epidermal growth factor on adipocyte differentiation was suggested to be induced by the reduction of peroxisome proliferator-activated receptor gamma 1 transcriptional activity caused by phosphorylation of peroxisome proliferator-activated receptor gamma 1 by mitogen-activated protein kinase (28). Taking these previous reports into consideration, it can be speculated that IRS-3 phosphorylated mainly on the plasma membrane, similarly to the receptors of epidermal growth factor or platelet-derived growth factor, may have a role promoting cell proliferation and inhibiting adipocyte differentiation. In addition to the functions of adipocytes discussed above, fat cells have more specific functions that are affected by insulin stimulation. It would be of great interest to clarify which IRS protein transduces the signal inducing the individual insulin-induced cell activity. Further study of this issue is needed.

    FOOTNOTES

* This work was supported by Grant-in-aid 09470214 for Scientific Research (to T. A.) from the Ministry of Education, Science, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 81-3-3815-5411 (ext. 3133); Fax: 81-3-5803-1874; E-mail: asano-tky{at}umin.ac.jp.

The abbreviations used are: PI 3-kinase, phosphatidylinositol 3-kinase; IRS insulin receptor substrate, PH, pleckstrin homology; PTB, phosphotyrosine binding; PM, plasma membrane; HDM, high density microsome; LDM, low density microsome; PVDF, polyvinylidene difluoride; PAGE, polyacrylamide gel electrophoresis.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Tanner, L. I., and Lienhard, G. E. (1987) J. Biol. Chem. 262, 8975-8980[Abstract/Free Full Text]
  2. Tanti, J. F., Gremeaux, T., Cormont, M., Van Obberghen, E., and Le Marchand-Brustel, Y. (1993) Am. J. Physiol. 264, E868-E873[Abstract/Free Full Text]
  3. Remesar, X., Rafecas, I., Fernandez-Lopez, J. A., and Alemany, M. (1997) FEBS Lett. 402, 9-11[CrossRef][Medline] [Order article via Infotrieve]
  4. Stephens, J. M., and Pilch, P. F. (1995) Endocr. Rev. 16, 529-546[Abstract/Free Full Text]
  5. Czech, M. P., Clancy, B. M., Pessino, A., Woon, C. W., and Harrison, S. A. (1992) Trends Biochem. Sci. 17, 197-201[CrossRef][Medline] [Order article via Infotrieve]
  6. Suzuki, K., and Kono, T. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 2542-2545[Abstract/Free Full Text]
  7. Yang, J., Clarke, J. F., Ester, C. J., Young, P. W., Kasuga, M., and Holman, G. D. (1996) Biochem. J. 313, 125-131
  8. Thies, R. S., Molina, J. M., Ciaraldi, T. P., Freidenberg, G. R., and Olefsky, J. M. (1990) Diabetes 39, 250-259[Abstract]
  9. Mooney, R. A., Bordwell, K. L., Luhowskyj, S., and Casnellie, J. E. (1989) Endocrinology 124, 422-429[Abstract/Free Full Text]
  10. Lavan, B. E., and Lienhard, G. E. (1993) J. Biol. Chem. 268, 5921-5928[Abstract/Free Full Text]
  11. Sciacchitano, S., and Taylor, S. I. (1997) Endocrinology 138, 4931-4940[Abstract/Free Full Text]
  12. Lavan, B. E., Lane, W. S., and Lienhard, G. E. (1997) J. Biol. Chem. 272, 11439-11443[Abstract/Free Full Text]
  13. Quon, M. J., Chen, H., Ing, B. L., Liu, M. L., Zarnowski, M. J., Yonezawa, K., Kasuga, M., Cushman, S. W., and Taylor, S. I. (1995) Mol. Cell. Biol. 15, 5403-5411[Abstract]
  14. Heller-Harrison, R. A., Morin, M., Guilherme, A., and Czech, M. P. (1996) J. Biol. Chem. 271, 10200-10204[Abstract/Free Full Text]
  15. Anai, M., Funaki, M., Ogihara, T., Terasaki, J., Inukai, K., Katagiri, H., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., and Asano, T. (1998) Diabetes 47, 13-23[Abstract]
  16. Robdell, M. (1964) J. Biol. Chem. 239, 375-380[Free Full Text]
  17. Simpson, I. A., Yver, D. R., Hissin, P. J., Wardzala, L. J., Karnieli, E., Salans, L. B., and Cushman, S. W. (1983) Biochim. Biophys. Acta 763, 393-407[Medline] [Order article via Infotrieve]
  18. Heller-Harrison, R. A., Morin, M., and Czech, M. P. (1995) J. Biol. Chem. 270, 24442-24450[Abstract/Free Full Text]
  19. Burks, D. J., Pons, S., Towery, H., Smith-Hall, J., Myers, M. G., Jr., Yenush, L., and White, M. F. (1997) J. Biol. Chem. 272, 27716-27721[Abstract/Free Full Text]
  20. Myers, M. G., Jr., Grammer, T. C., Brooks, J., Glasheen, E. M., Wang, L. M., Sun, X. J., Blenis, J., Pierce, J. H., and White, M. F. (1995) J. Biol. Chem. 270, 11715-11718[Abstract/Free Full Text]
  21. Sawka-Verhelle, D., Tartare-Deckert, S., White, M. F., and Van Obberghen, E. (1996) J. Biol. Chem. 271, 5980-5983[Abstract/Free Full Text]
  22. Terasaki, J., Anai, M., Funaki, M., Shibata, T., Inukai, K., Ogihara, T., Ishihara, H., Katagiri, H., Onishi, Y., Sakoda, H., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., and Asano, T. (1998) Diabetologia 41, 400-409[CrossRef][Medline] [Order article via Infotrieve]
  23. Grundleger, M. L., and Thenen, S. W. (1982) Diabetes 31, 232-237[Abstract]
  24. Hissin, P. J., Karnieli, E., Simpson, I. A., Salans, L. B., and Cushman, S. W. (1982) Diabetes 31, 589-592[Abstract]
  25. Pedersen, O., Kahn, C. R., Flier, J. S., and Kahn, B. B. (1991) Endocrinology 129, 771-777[Abstract/Free Full Text]
  26. Zierath, J. R., Houseknecht, K. L., Gnudi, L., and Kahn, B. B. (1997) Diabetes 46, 215-223[Abstract]
  27. Hauner, H., Rohrig, K., and Petruschke, T. (1995) Eur. J. Clin. Invest. 25, 90-96[Medline] [Order article via Infotrieve]
  28. Camp, H. S., and Tafuri, S. R. (1997) J. Biol. Chem. 272, 10811-10816[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R Serrano, M Villar, C Martinez, J M Carrascosa, N Gallardo, and A Andres
Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue
J. Mol. Endocrinol., February 1, 2005; 34(1): 153 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bedirian, C. Baldwin, J.-i. Abe, T. Takano, and S. Lemay
Pleckstrin Homology and Phosphotyrosine-binding Domain-dependent Membrane Association and Tyrosine Phosphorylation of Dok-4, an Inhibitory Adapter Molecule Expressed in Epithelial Cells
J. Biol. Chem., April 30, 2004; 279(18): 19335 - 19349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sasaoka, T. Wada, K. Fukui, S. Murakami, H. Ishihara, R. Suzuki, K. Tobe, T. Kadowaki, and M. Kobayashi
SH2-containing Inositol Phosphatase 2 Predominantly Regulates Akt2, and Not Akt1, Phosphorylation at the Plasma Membrane in Response to Insulin in 3T3-L1 Adipocytes
J. Biol. Chem., April 9, 2004; 279(15): 14835 - 14843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Maffucci, G. Razzini, A. Ingrosso, H. Chen, S. Iacobelli, S. Sciacchitano, M. J. Quon, and M. Falasca
Role of Pleckstrin Homology Domain in Regulating Membrane Targeting and Metabolic Function of Insulin Receptor Substrate 3
Mol. Endocrinol., August 1, 2003; 17(8): 1568 - 1579.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Schreyer, D. Ledwig, I. Rakatzi, I. Kloting, and J. Eckel
Insulin Receptor Substrate-4 Is Expressed in Muscle Tissue without Acting as a Substrate for the Insulin Receptor
Endocrinology, April 1, 2003; 144(4): 1211 - 1218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. D. Borge Jr. and B. A. Wolf
Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting beta -Cells
J. Biol. Chem., March 21, 2003; 278(13): 11359 - 11368.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Farhang-Fallah, V. K. Randhawa, A. Nimnual, A. Klip, D. Bar-Sagi, and M. Rozakis-Adcock
The Pleckstrin Homology (PH) Domain-Interacting Protein Couples the Insulin Receptor Substrate 1 PH Domain to Insulin Signaling Pathways Leading to Mitogenesis and GLUT4 Translocation
Mol. Cell. Biol., October 15, 2002; 22(20): 7325 - 7336.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Sciacchitano, A. Orecchio, L. Lavra, S. Misiti, A. Giacchini, M. Zani, D. Danese, A. Gurtner, S. Soddu, U. Di Mario, et al.
Cloning of the Mouse Insulin Receptor Substrate-3 (mIRS-3) Promoter, and Its Regulation by p53
Mol. Endocrinol., July 1, 2002; 16(7): 1577 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kabuta, F. Hakuno, T. Asano, and S.-I. Takahashi
Insulin Receptor Substrate-3 Functions as Transcriptional Activator in the Nucleus
J. Biol. Chem., February 22, 2002; 277(9): 6846 - 6851.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
FASEB J, October 1, 2001; 15(12): 2099 - 2111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Oku, M. Nawano, K. Ueta, T. Fujita, I. Umebayashi, K. Arakawa, T. Kano-Ishihara, A. Saito, M. Anai, M. Funaki, et al.
Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E816 - E824.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Ogihara, T. Asano, K. Ando, Y. Chiba, N. Sekine, H. Sakoda, M. Anai, Y. Onishi, M. Fujishiro, H. Ono, et al.
Insulin Resistance With Enhanced Insulin Signaling in High-Salt Diet-Fed Rats
Diabetes, March 1, 2001; 50(3): 573 - 583.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
K. Tsuruzoe, R. Emkey, K. M. Kriauciunas, K. Ueki, and C. R. Kahn
Insulin Receptor Substrate 3 (IRS-3) and IRS-4 Impair IRS-1- and IRS-2-Mediated Signaling
Mol. Cell. Biol., January 1, 2001; 21(1): 26 - 38.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
G. Razzini, A. Ingrosso, A. Brancaccio, S. Sciacchitano, D. L. Esposito, and M. Falasca
Different Subcellular Localization and Phosphoinositides Binding of Insulin Receptor Substrate Protein Pleckstrin Homology Domains
Mol. Endocrinol., June 1, 2000; 14(6): 823 - 836.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. F. Clark, J.-C. Molero, and D. E. James
Release of Insulin Receptor Substrate Proteins from an Intracellular Complex Coincides with the Development of Insulin Resistance
J. Biol. Chem., February 11, 2000; 275(6): 3819 - 3826.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. B. Knight, K. T. Cao, G. V. Gibson, and A. L. Olson
Expression of a Prenylation-Deficient Rab4 Interferes with Propagation of Insulin Signaling through Insulin Receptor Substrate-1
Endocrinology, January 1, 2000; 141(1): 208 - 218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. R. Fantin, Q. Wang, G. E. Lienhard, and S. R. Keller
Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis
Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E127 - E133.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M.-A. Abbott, D. G. Wells, and J. R. Fallon
The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses
J. Neurosci., September 1, 1999; 19(17): 7300 - 7308.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. H. Liu, Q. Wang, G. E. Lienhard, and S. R. Keller
Insulin Receptor Substrate 3 Is Not Essential for Growth or Glucose Homeostasis
J. Biol. Chem., June 18, 1999; 274(25): 18093 - 18099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Xu, A. R. Jacobs, and S. I. Taylor
Interaction of Insulin Receptor Substrate 3 with Insulin Receptor, Insulin Receptor-related Receptor, Insulin-like Growth Factor-1 Receptor, and Downstream Signaling Proteins
J. Biol. Chem., May 21, 1999; 274(21): 15262 - 15270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Miyakawa, P. Rojnuckarin, T. Habib, and K. Kaushansky
Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes
J. Biol. Chem., January 19, 2001; 276(4): 2494 - 2502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Olson, A. R. Trumbly, and G. V. Gibson
Insulin-mediated GLUT4 Translocation Is Dependent on the Microtubule Network
J. Biol. Chem., March 30, 2001; 276(14): 10706 - 10714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Jacobs, D. LeRoith, and S. I. Taylor
Insulin Receptor Substrate-1 Pleckstrin Homology and Phosphotyrosine-binding Domains Are Both Involved in Plasma Membrane Targeting
J. Biol. Chem., October 26, 2001; 276(44): 40795 - 40802.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anai, M.
Right arrow Articles by Asano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anai, M.
Right arrow Articles by Asano, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement